Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportFiling
2020-02-14
3:52 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		Anson Funds Management LP640,270
1.6%		201,250increase
(+45.84%)		View
2020-02-14
11:22 am
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		ARMISTICE CAPITAL, LLC1,755,156
4.99%		1,498,640increase
(+584.23%)		View
2020-01-09
3:46 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		SABBY MANAGEMENT, LLC1,667,574
11%		1,228,554increase
(+279.84%)		View
2019-12-20
4:17 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		INTRACOASTAL CAPITAL, LLC1,607,936
4.99%		1,081,535increase
(+205.46%)		View
2019-11-22
5:31 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		INTRACOASTAL CAPITAL, LLC526,401
4.99%		526,401increase
(New Position)		View
2019-06-03
5:21 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		ARMISTICE CAPITAL, LLC256,516
5.5%		256,516increase
(New Position)		View
2019-06-03
08:39 am
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		Anson Funds Management LP439,020
9.4%		439,020increase
(New Position)		View
2019-05-28
2:58 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		SABBY MANAGEMENT, LLC439,020
11%		439,020increase
(New Position)		View
2018-01-29
2:02 pm
Purchase		13GDiffusion Pharmaceuticals Inc.
DFFN		Ally Bridge Group Capital Partners II, L.P.1,860,055
3.68%		726,774increase
(+64.13%)		View